Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
GE Medical Systems (GEMS) has unveiled the next generation of its Millennium MyoSight dual-detector, variable-angle system for office-based nuclear cardiology imaging.
Agfa Healthcare Australia is set to embark on a $17 million contract for its PACS and RIS system to support image management in a number of tertiary hospitals in Western Australia (WA).
What's new and exciting in DICOM? The question will be answered in Baltimore, Md., as the DICOM Standards Committee hosts its first-ever DICOM anniversary conference Sept. 22-23.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
